Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines

• Autors principals: Omar M. Albalawi (Autor), Maha I. Alomran (Autor), Ghada M. Alsagri (Autor), Turki A. Althunian (Autor), Thamir M. Alshammari (Autor)
• Format: Llibre
• Publicat: Elsevier, 2022-02-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Introduction: Since December 2020, three COVID-19 vaccines have been authorized in the United States (U.S.) and were proceeded by large immunization programs. The aim of this study was to characterize the U.S. post-marketing safety (PMS) profiles of these vaccines with an in-depth analysis of mortal...